Fluorine in PDB 3omo: Fragment-Based Design of Novel Estrogen Receptor Ligands
Protein crystallography data
The structure of Fragment-Based Design of Novel Estrogen Receptor Ligands, PDB code: 3omo
was solved by
S.Moecklinghoff,
W.A.Van Otterlo,
R.Rose,
S.Fuchs,
M.Dominguez Seoane,
H.Waldmann,
C.Ottmann,
L.Brunsveld,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.54 /
2.21
|
Space group
|
P 31
|
Cell size a, b, c (Å), α, β, γ (°)
|
70.570,
70.570,
109.990,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
20.8 /
26.4
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Fragment-Based Design of Novel Estrogen Receptor Ligands
(pdb code 3omo). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Fragment-Based Design of Novel Estrogen Receptor Ligands, PDB code: 3omo:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 3omo
Go back to
Fluorine Binding Sites List in 3omo
Fluorine binding site 1 out
of 6 in the Fragment-Based Design of Novel Estrogen Receptor Ligands
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Fragment-Based Design of Novel Estrogen Receptor Ligands within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1
b:24.3
occ:1.00
|
FAC
|
A:WV71
|
0.0
|
24.3
|
1.0
|
CAQ
|
A:WV71
|
1.3
|
26.9
|
1.0
|
CAL
|
A:WV71
|
2.2
|
24.2
|
1.0
|
FAD
|
A:WV71
|
2.2
|
24.3
|
1.0
|
FAE
|
A:WV71
|
2.3
|
30.9
|
1.0
|
OAA
|
A:WV71
|
2.3
|
25.0
|
1.0
|
NAP
|
A:WV71
|
3.5
|
19.4
|
1.0
|
O
|
A:GLY472
|
3.5
|
13.8
|
1.0
|
CD1
|
A:LEU476
|
3.7
|
17.4
|
1.0
|
CA
|
A:GLY472
|
3.8
|
13.5
|
1.0
|
CB
|
A:HIS475
|
4.0
|
20.8
|
1.0
|
ND1
|
A:HIS475
|
4.0
|
29.4
|
1.0
|
C
|
A:GLY472
|
4.1
|
14.5
|
1.0
|
CAJ
|
A:WV71
|
4.3
|
19.4
|
1.0
|
CD1
|
A:ILE373
|
4.3
|
13.0
|
1.0
|
CG
|
A:HIS475
|
4.3
|
23.0
|
1.0
|
CD1
|
A:ILE376
|
4.3
|
10.5
|
1.0
|
CD2
|
A:LEU476
|
4.5
|
15.9
|
1.0
|
CG
|
A:LEU476
|
4.5
|
22.9
|
1.0
|
CG1
|
A:ILE373
|
4.5
|
14.5
|
1.0
|
CE
|
A:MET336
|
4.6
|
15.8
|
1.0
|
N
|
A:LEU476
|
4.6
|
21.5
|
1.0
|
CAK
|
A:WV71
|
4.6
|
13.0
|
1.0
|
CE
|
A:MET295
|
4.6
|
6.7
|
1.0
|
CB
|
A:LEU476
|
4.9
|
22.2
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 3omo
Go back to
Fluorine Binding Sites List in 3omo
Fluorine binding site 2 out
of 6 in the Fragment-Based Design of Novel Estrogen Receptor Ligands
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Fragment-Based Design of Novel Estrogen Receptor Ligands within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1
b:24.3
occ:1.00
|
FAD
|
A:WV71
|
0.0
|
24.3
|
1.0
|
CAQ
|
A:WV71
|
1.3
|
26.9
|
1.0
|
FAE
|
A:WV71
|
2.1
|
30.9
|
1.0
|
FAC
|
A:WV71
|
2.2
|
24.3
|
1.0
|
CAL
|
A:WV71
|
2.4
|
24.2
|
1.0
|
CAJ
|
A:WV71
|
2.9
|
19.4
|
1.0
|
NAP
|
A:WV71
|
2.9
|
19.4
|
1.0
|
CA
|
A:GLY472
|
3.1
|
13.5
|
1.0
|
OAA
|
A:WV71
|
3.3
|
25.0
|
1.0
|
CE
|
A:MET340
|
3.5
|
19.9
|
1.0
|
CG2
|
A:ILE376
|
3.8
|
13.7
|
1.0
|
CAI
|
A:WV71
|
3.9
|
16.0
|
1.0
|
CE
|
A:MET336
|
4.0
|
15.8
|
1.0
|
C
|
A:GLY472
|
4.0
|
14.5
|
1.0
|
SD
|
A:MET336
|
4.1
|
17.3
|
1.0
|
O
|
A:GLY472
|
4.1
|
13.8
|
1.0
|
CD1
|
A:ILE376
|
4.2
|
10.5
|
1.0
|
N
|
A:GLY472
|
4.3
|
14.5
|
1.0
|
CAK
|
A:WV71
|
4.4
|
13.0
|
1.0
|
CB
|
A:ILE376
|
4.9
|
11.9
|
1.0
|
CG1
|
A:ILE376
|
4.9
|
12.1
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 3omo
Go back to
Fluorine Binding Sites List in 3omo
Fluorine binding site 3 out
of 6 in the Fragment-Based Design of Novel Estrogen Receptor Ligands
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Fragment-Based Design of Novel Estrogen Receptor Ligands within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1
b:30.9
occ:1.00
|
FAE
|
A:WV71
|
0.0
|
30.9
|
1.0
|
CAQ
|
A:WV71
|
1.3
|
26.9
|
1.0
|
FAD
|
A:WV71
|
2.1
|
24.3
|
1.0
|
FAC
|
A:WV71
|
2.3
|
24.3
|
1.0
|
CAL
|
A:WV71
|
2.3
|
24.2
|
1.0
|
NAP
|
A:WV71
|
3.0
|
19.4
|
1.0
|
CAJ
|
A:WV71
|
3.1
|
19.4
|
1.0
|
OAA
|
A:WV71
|
3.1
|
25.0
|
1.0
|
CD1
|
A:ILE373
|
3.1
|
13.0
|
1.0
|
CG2
|
A:ILE376
|
3.5
|
13.7
|
1.0
|
CG1
|
A:ILE373
|
3.6
|
14.5
|
1.0
|
CD1
|
A:ILE376
|
3.9
|
10.5
|
1.0
|
CB
|
A:ILE376
|
4.2
|
11.9
|
1.0
|
CAK
|
A:WV71
|
4.3
|
13.0
|
1.0
|
CAI
|
A:WV71
|
4.6
|
16.0
|
1.0
|
CG1
|
A:ILE376
|
4.6
|
12.1
|
1.0
|
CA
|
A:GLY472
|
4.6
|
13.5
|
1.0
|
CE1
|
A:PHE377
|
4.8
|
8.5
|
1.0
|
CB
|
A:ILE373
|
5.0
|
14.1
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 3omo
Go back to
Fluorine Binding Sites List in 3omo
Fluorine binding site 4 out
of 6 in the Fragment-Based Design of Novel Estrogen Receptor Ligands
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Fragment-Based Design of Novel Estrogen Receptor Ligands within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1
b:23.2
occ:1.00
|
FAC
|
B:WV71
|
0.0
|
23.2
|
1.0
|
CAQ
|
B:WV71
|
1.4
|
23.8
|
1.0
|
CAL
|
B:WV71
|
2.2
|
22.4
|
1.0
|
FAE
|
B:WV71
|
2.3
|
28.4
|
1.0
|
FAD
|
B:WV71
|
2.3
|
15.1
|
1.0
|
OAA
|
B:WV71
|
2.3
|
21.0
|
1.0
|
O
|
B:GLY472
|
3.4
|
12.8
|
1.0
|
NAP
|
B:WV71
|
3.5
|
18.5
|
1.0
|
CA
|
B:GLY472
|
3.7
|
13.2
|
1.0
|
CD1
|
B:LEU476
|
3.8
|
20.5
|
1.0
|
CB
|
B:HIS475
|
3.9
|
21.1
|
1.0
|
C
|
B:GLY472
|
3.9
|
14.4
|
1.0
|
ND1
|
B:HIS475
|
4.0
|
28.1
|
1.0
|
CG
|
B:HIS475
|
4.2
|
23.7
|
1.0
|
CAJ
|
B:WV71
|
4.3
|
17.6
|
1.0
|
CD1
|
B:ILE376
|
4.4
|
9.9
|
1.0
|
CD1
|
B:ILE373
|
4.5
|
15.1
|
1.0
|
CD2
|
B:LEU476
|
4.5
|
17.5
|
1.0
|
CAK
|
B:WV71
|
4.5
|
14.1
|
1.0
|
CG
|
B:LEU476
|
4.6
|
23.0
|
1.0
|
CG1
|
B:ILE373
|
4.6
|
16.1
|
1.0
|
N
|
B:LEU476
|
4.7
|
21.7
|
1.0
|
CE
|
B:MET336
|
4.7
|
10.9
|
1.0
|
CE
|
B:MET295
|
4.7
|
4.8
|
1.0
|
CB
|
B:LEU476
|
4.9
|
22.8
|
1.0
|
N
|
B:GLY472
|
5.0
|
13.5
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 3omo
Go back to
Fluorine Binding Sites List in 3omo
Fluorine binding site 5 out
of 6 in the Fragment-Based Design of Novel Estrogen Receptor Ligands
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Fragment-Based Design of Novel Estrogen Receptor Ligands within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1
b:15.1
occ:1.00
|
FAD
|
B:WV71
|
0.0
|
15.1
|
1.0
|
CAQ
|
B:WV71
|
1.3
|
23.8
|
1.0
|
FAE
|
B:WV71
|
2.0
|
28.4
|
1.0
|
FAC
|
B:WV71
|
2.3
|
23.2
|
1.0
|
CAL
|
B:WV71
|
2.3
|
22.4
|
1.0
|
CAJ
|
B:WV71
|
2.8
|
17.6
|
1.0
|
NAP
|
B:WV71
|
2.8
|
18.5
|
1.0
|
CA
|
B:GLY472
|
3.3
|
13.2
|
1.0
|
OAA
|
B:WV71
|
3.3
|
21.0
|
1.0
|
CAI
|
B:WV71
|
3.7
|
15.3
|
1.0
|
CG2
|
B:ILE376
|
3.7
|
14.9
|
1.0
|
CE
|
B:MET340
|
4.0
|
21.4
|
1.0
|
SD
|
B:MET336
|
4.2
|
15.2
|
1.0
|
C
|
B:GLY472
|
4.2
|
14.4
|
1.0
|
CAK
|
B:WV71
|
4.2
|
14.1
|
1.0
|
CD1
|
B:ILE376
|
4.3
|
9.9
|
1.0
|
O
|
B:GLY472
|
4.3
|
12.8
|
1.0
|
N
|
B:GLY472
|
4.4
|
13.5
|
1.0
|
CE
|
B:MET336
|
4.4
|
10.9
|
1.0
|
CB
|
B:ILE376
|
4.8
|
11.2
|
1.0
|
CAO
|
B:WV71
|
4.9
|
12.6
|
1.0
|
CG1
|
B:ILE376
|
4.9
|
9.6
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 3omo
Go back to
Fluorine Binding Sites List in 3omo
Fluorine binding site 6 out
of 6 in the Fragment-Based Design of Novel Estrogen Receptor Ligands
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Fragment-Based Design of Novel Estrogen Receptor Ligands within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1
b:28.4
occ:1.00
|
FAE
|
B:WV71
|
0.0
|
28.4
|
1.0
|
CAQ
|
B:WV71
|
1.3
|
23.8
|
1.0
|
FAD
|
B:WV71
|
2.0
|
15.1
|
1.0
|
CAL
|
B:WV71
|
2.2
|
22.4
|
1.0
|
FAC
|
B:WV71
|
2.3
|
23.2
|
1.0
|
NAP
|
B:WV71
|
3.0
|
18.5
|
1.0
|
OAA
|
B:WV71
|
3.0
|
21.0
|
1.0
|
CD1
|
B:ILE373
|
3.1
|
15.1
|
1.0
|
CAJ
|
B:WV71
|
3.2
|
17.6
|
1.0
|
CG1
|
B:ILE373
|
3.5
|
16.1
|
1.0
|
CG2
|
B:ILE376
|
3.6
|
14.9
|
1.0
|
CD1
|
B:ILE376
|
3.9
|
9.9
|
1.0
|
CB
|
B:ILE376
|
4.2
|
11.2
|
1.0
|
CAK
|
B:WV71
|
4.3
|
14.1
|
1.0
|
CAI
|
B:WV71
|
4.6
|
15.3
|
1.0
|
CA
|
B:GLY472
|
4.6
|
13.2
|
1.0
|
CG1
|
B:ILE376
|
4.7
|
9.6
|
1.0
|
CE1
|
B:PHE377
|
4.8
|
9.4
|
1.0
|
CB
|
B:ILE373
|
4.9
|
15.8
|
1.0
|
|
Reference:
W.A.Van Otterlo,
R.Rose,
S.Fuchs,
T.J.Zimmermann,
M.Dominguez Seoane,
H.Waldmann,
C.Ottmann,
L.Brunsveld.
Design and Evaluation of Fragment-Like Estrogen Receptor Tetrahydroisoquinoline Ligands From A Scaffold-Detection Approach. J.Med.Chem. V. 54 2005 2011.
ISSN: ISSN 0022-2623
PubMed: 21381753
DOI: 10.1021/JM1011116
Page generated: Wed Jul 31 21:15:25 2024
|